Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Capitalization 5.86B 827M 6.45B 1.12B P/E ratio 2023 *
27.8x
P/E ratio 2024 * 27.2x
Enterprise value 5.86B 827M 6.45B 1.12B EV / Sales 2023 *
2.91x
EV / Sales 2024 * -
Free-Float
76.11%
Yield 2023 *
-
Yield 2024 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-19.75%
6 months-27.49%
Current year-38.92%
More quotes
Current year
13.76
Extreme 13.76
23.45
1 year
13.76
Extreme 13.76
26.30
3 years
12.70
Extreme 12.7
43.00
5 years
12.70
Extreme 12.7
89.65
10 years
12.70
Extreme 12.7
89.65
More quotes
Director TitleAgeSince
Chief Executive Officer 52 18-06-06
Founder - 18-06-06
Director of Finance/CFO 41 20-05-31
Manager TitleAgeSince
Founder - 18-06-06
Director/Board Member 54 21-02-16
Director/Board Member 66 21-02-16
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-19.75%-.--%-25.58%-68.40%814M
-1.58%+0.86%+13.99%-4.39%13.84B
-0.81%+0.57%+12.63%+44.44%7.45B
-3.19%-4.22%+54.14%+289.68%7.08B
-0.39%-2.74%+8.18%-49.48%5.99B
+0.80%+2.43%+84.40%-50.20%3.34B
-1.72%-2.06%-12.47%-21.49%3.26B
-1.18%+1.07%+18.06%+487.05%2.78B
-6.91%-7.75%-57.07%-88.72%2.6B
-2.49%-4.80%+63.65%-23.60%2.45B
Average -3.72%-3.13%+15.99%+51.49% 4.96B
Weighted average by Cap. -2.00%-0.79%+20.13%+56.46%
See all sector performances

Financials

2023 *2024 *
Net sales 2.01B 284M 2.22B 385M -
Net income 218M 30.78M 240M 41.75M 218M 30.78M 240M 41.75M
Net Debt - -
More financial data * Estimated data
Logo New Horizon Health Limited
New Horizon Health Ltd is a China-based investment holding company principally engaged in the research, development, clinical development, test operation and commercialization of screening products for colorectal cancer, gastric cancer and cervical cancer. The Company distributes its ColoClear, Pupu tube and other products to customers through its own network, contracted sales organisations (CSOs) and Internet sales or e-platform operated by healthcare clinics. The Company’s Youyou Tube (a stool-based self-checking gastric cancer screening test) and CerviClear (a non-invasive urine cervical cancer home screening test) are under development.
Employees
1,041
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
14.14
Average target price
-
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW